Alcon Q1 2023 Earnings Presentation
Q1 2023 Vision Care
Double-digit Vision Care growth reflects strength in
contact lenses and eye drops, including
acquired products
+
+
Alcon
●
●
●
●
●
Solid global contact lens market growth
ALC above-market growth, particularly in US, with silicone hydrogel
contact lenses, including Precision 1 and Total product families
Price increases across the contact lens portfolio
Strong demand for portfolio of eye drops, including Rocklatan and
Rhopressa; approximately 5 percentage points of growth contribution to
Vision Care from products acquired in 2022
Price increases across the over-the-counter portfolio, including Systane
-400 bps of negative impact from FX on Vision Care sales growth
1. Constant currency growth is a non-IFRS measure. An explanation of non-IFRS measures can be found in the Appendix.
$916
$557
Net Sales
(USD $M)
$359
1Q22
$1,029
$615
$414
1Q23
Contact lenses
Ocular health
(USD) (CC)¹
12%
10% 14%
15%
16%
14
19%View entire presentation